BARD1 Life Sciences Ltd raises $15 million to accelerate cancer diagnostic test development
BARD1 Life Sciences raises $15 million to accelerate cancer diagnostic test development Chairman Dr Geoff Cumming said: “The capital raising was strongly supported by new and existing institutional and sophisticated investors with a deep understanding of the biotechnology sector and importance of early cancer detection on patient outcomes.” Shareholders will be offered the opportunity to participate in a Share Purchase Plan to raise up to a further $2 million. BARD1 Life Sciences Ltd has raised $15 million in a placement to sophisticated, institutional and professional investo...